Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 8.09 Million CAD | 579.81% |
| 2023 | -1.68 Million CAD | 83.19% |
| 2022 | -10.03 Million CAD | -5.53% |
| 2021 | -9.5 Million CAD | -120.91% |
| 2020 | -4.3 Million CAD | 0.0% |
| 2019 | -4.3 Million CAD | 6.67% |
| 2018 | -4.61 Million CAD | -406.34% |
| 2017 | -910.48 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -320.16 Thousand CAD | 81.01% |
| 2024 Q2 | 2.98 Million CAD | 1033.56% |
| 2024 FY | 8.09 Million CAD | 579.81% |
| 2024 Q4 | 8.09 Million CAD | 9.19% |
| 2024 Q3 | 7.4 Million CAD | 147.89% |
| 2023 Q1 | -320.16 Thousand CAD | 81.01% |
| 2023 Q3 | 4.01 Million CAD | 34.3% |
| 2023 Q4 | -1.68 Million CAD | -142.01% |
| 2023 Q2 | 2.98 Million CAD | 1033.56% |
| 2023 FY | -1.68 Million CAD | 83.19% |
| 2022 Q2 | -6.18 Million CAD | 25.39% |
| 2022 Q1 | -8.28 Million CAD | 17.38% |
| 2022 FY | -10.03 Million CAD | -5.53% |
| 2022 Q4 | -1.68 Million CAD | 73.53% |
| 2022 Q3 | -6.37 Million CAD | -3.02% |
| 2021 Q2 | -11.84 Million CAD | -161.95% |
| 2021 FY | -9.5 Million CAD | -120.91% |
| 2021 Q4 | -10.03 Million CAD | 29.35% |
| 2021 Q1 | -4.52 Million CAD | 52.43% |
| 2021 Q3 | -14.19 Million CAD | -19.87% |
| 2020 FY | -4.3 Million CAD | 0.0% |
| 2020 Q3 | -1.39 Million CAD | 31.33% |
| 2020 Q2 | -2.03 Million CAD | 35.94% |
| 2020 Q1 | -3.17 Million CAD | 26.21% |
| 2020 Q4 | -9.5 Million CAD | -580.64% |
| 2019 Q4 | -4.3 Million CAD | -16.68% |
| 2019 Q3 | -3.68 Million CAD | 0.0% |
| 2019 FY | -4.3 Million CAD | 6.67% |
| 2019 Q1 | 5.75 Million CAD | 224.77% |
| 2018 Q4 | -4.61 Million CAD | 0.0% |
| 2018 FY | -4.61 Million CAD | -406.34% |
| 2017 FY | -910.48 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 48.675% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -96.462% |
| SQZ Biotechnologies Company | -36.23 Million USD | 122.326% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 81.094% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 228.326% |
| Mesoblast Limited | 55.85 Million USD | 85.516% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -772.572% |
| Genus plc | 190.6 Million USD | 95.755% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -261.85% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -566.483% |
| Marizyme, Inc. | 18.56 Million USD | 56.431% |
| ContraFect Corporation | -6.02 Million USD | 234.258% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -1089.759% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -5908.93% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -600.204% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -260.817% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -47.047% |
| MultiCell Technologies, Inc. | 90.04 USD | -8985198.756% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 1202.262% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 37.507% |
| EV Biologics, Inc. | 1.36 Million USD | -491.413% |
| Q BioMed Inc. | 4.06 Million USD | -99.27% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 73.521% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -1199.941% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -702.842% |
| Biomind Labs Inc. | 711.4 Thousand USD | -1037.242% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 92.632% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 36.827% |
| Skye Bioscience, Inc. | -5.72 Million USD | 241.406% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -840.476% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -5686.932% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -43.234% |
| IMV Inc. | 7.67 Million USD | -5.473% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -40622.62% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -267.413% |
| GB Sciences, Inc. | 1.74 Million USD | -363.017% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 4502.008% |
| HST Global, Inc. | 96.79 Thousand USD | -8258.417% |
| CSL Limited | 10.52 Billion USD | 99.923% |
| Halberd Corporation | 144.72 Thousand USD | -5490.317% |
| Enzolytics Inc. | 981.65 Thousand USD | -724.155% |
| Resverlogix Corp. | 6.45 Million USD | -25.413% |
| Affymax, Inc. | -5.59 Million USD | 244.548% |
| SYBLEU INC | 473.71 Thousand USD | -1607.858% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 1301.975% |
| argenx SE | -2.02 Billion USD | 100.399% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 81.373% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 117.209% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -198.69% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 191.521% |
| AVAX Technologies, Inc. | -5.9 Million USD | 237.05% |
| Zenith Capital Corp. | 10.06 Thousand USD | -80289.14% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.762% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -3936.463% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -239.072% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -4817.885% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 86.638% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -304.641% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 414.796% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2149.135% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 60.099% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 44266.192% |
| BioStem Technologies, Inc. | 4.47 Million USD | -80.911% |
| ONE Bio Corp. | 9.04 Million USD | 10.505% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -3919.976% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 617684.962% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -3823.228% |
| Agentix Corp. | 37.63 Thousand USD | -21399.197% |
| LadRx Corporation | -2.03 Million USD | 497.274% |
| Cell Source, Inc. | 9.23 Million USD | 12.366% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 39743.096% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1173.738% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1173.738% |
| NovAccess Global Inc. | 2.17 Million USD | -271.379% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -14.417% |
| Itoco Inc. | 228.3 Thousand USD | -3443.664% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -5849.278% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -63.211% |
| Kadimastem Ltd | -253.1 Thousand USD | 3296.483% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -1913.284% |
| CytoDyn Inc. | 20.26 Million USD | 60.071% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 1250542.504% |
| Mobile Lads Corp. | 484.23 Thousand USD | -1570.762% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 87390.313% |
| Qrons Inc. | 351.42 Thousand USD | -2202.146% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -4.988% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 3341.072% |
| Rebus Holdings, Inc. | 305 Thousand USD | -2552.578% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -81.519% |
| International Stem Cell Corporation | 2.59 Million USD | -212.369% |
| Bioxytran, Inc. | 1.89 Million USD | -326.052% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -12862.625% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -270.964% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -135.596% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 5.409% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -947.151% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 747.229% |
| Neutra Corp. | 52.18 Thousand USD | -15402.641% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 425.045% |
| PureTech Health plc | -167.19 Million USD | 104.839% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 3403.429% |
| IXICO plc | -4.44 Million USD | 282.027% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 38.797% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 85.25% |
| CSL Limited | 10.52 Billion USD | 99.923% |
| Cellectis S.A. | -43.81 Million USD | 118.463% |